BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28268092)

  • 1. Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia.
    Brunetti C; Anelli L; Zagaria A; Minervini A; Minervini CF; Casieri P; Coccaro N; Cumbo C; Tota G; Impera L; Orsini P; Specchia G; Albano F
    J Mol Diagn; 2017 May; 19(3):437-444. PubMed ID: 28268092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a droplet digital PCR assay for the evaluation of PML-RARα fusion transcripts in acute promyelocytic leukemia.
    Jiang XW; Chen SZ; Zhu XY; Xu XX; Liu Y
    Mol Cell Probes; 2020 Oct; 53():101617. PubMed ID: 32585184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia.
    Iaccarino L; Divona M; Ottone T; Cicconi L; Lavorgna S; Ciardi C; Alfonso V; Travaglini S; Facchini L; Cimino G; Di Bona E; Voso MT; Lo-Coco F
    Genes Chromosomes Cancer; 2019 Jan; 58(1):60-65. PubMed ID: 30421475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a 3-Plex RT-qPCR assay for the simultaneous detection and quantitation of the three PML-RARa fusion transcripts in acute promyelocytic leukemia.
    Chen Z; Tong Y; Li Y; Gao Q; Wang Q; Fu C; Xia Z
    PLoS One; 2015; 10(3):e0122530. PubMed ID: 25815789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Droplet Digital PCR for Minimal Residual Disease Detection in Mature Lymphoproliferative Disorders.
    Drandi D; Ferrero S; Ladetto M
    Methods Mol Biol; 2018; 1768():229-256. PubMed ID: 29717447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Droplet digital PCR for quantification of PML-RARα in acute promyelocytic leukemia: a comprehensive comparison with real-time PCR.
    Yuan D; Cui M; Yu S; Wang H; Jing R
    Anal Bioanal Chem; 2019 Feb; 411(4):895-903. PubMed ID: 30617397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of PML/RARa transcripts in acute promyelocytic leukemia by real-time quantitative reverse transcription polymerase chain reaction].
    Lang L; Li HM; Liu H; Wang YM; Zhang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):714-9. PubMed ID: 17708789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.
    Drandi D; Kubiczkova-Besse L; Ferrero S; Dani N; Passera R; Mantoan B; Gambella M; Monitillo L; Saraci E; Ghione P; Genuardi E; Barbero D; Omedè P; Barberio D; Hajek R; Vitolo U; Palumbo A; Cortelazzo S; Boccadoro M; Inghirami G; Ladetto M
    J Mol Diagn; 2015 Nov; 17(6):652-60. PubMed ID: 26319783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia.
    Coccaro N; Anelli L; Zagaria A; Casieri P; Tota G; Orsini P; Impera L; Minervini A; Minervini CF; Cumbo C; Parciante E; Carluccio P; Brunetti C; Specchia G; Albano F
    J Mol Diagn; 2018 Jul; 20(4):474-482. PubMed ID: 29625246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RARalpha transcripts with a sensitive competitive RT-PCR method.
    Tobal K; Moore H; Macheta M; Yin JA
    Leukemia; 2001 Jul; 15(7):1060-5. PubMed ID: 11455974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia.
    Albano F; Zagaria A; Anelli L; Coccaro N; Tota G; Brunetti C; Minervini CF; Impera L; Minervini A; Cellamare A; Orsini P; Cumbo C; Casieri P; Specchia G
    Oncotarget; 2015 May; 6(15):13269-77. PubMed ID: 25944686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia.
    Nunes V; Cazzaniga G; Biondi A
    Expert Rev Mol Diagn; 2017 Nov; 17(11):953-963. PubMed ID: 28891364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia.
    Della Starza I; Nunes V; Cavalli M; De Novi LA; Ilari C; Apicella V; Vitale A; Testi AM; Del Giudice I; Chiaretti S; Foà R; Guarini A
    Br J Haematol; 2016 Aug; 174(4):541-9. PubMed ID: 27172403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation.
    Perego RA; Marenco P; Bianchi C; Cairoli R; Urbano M; Nosari AM; Muti G; Morra E; Del Monte U
    Leukemia; 1996 Feb; 10(2):207-12. PubMed ID: 8637228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferring measurable residual disease measurement in pediatric acute lymphoblastic leukemia from quantitative real-time PCR to digital droplet PCR.
    Luib L; Kreyenberg H; Michaelis S; Handgretinger R; Mezger M
    Pediatr Transplant; 2023 Jun; 27(4):e14483. PubMed ID: 36750990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New View on Minimal Residual Disease Quantification in Acute Lymphoblastic Leukemia using Droplet Digital PCR.
    Schwinghammer C; Koopmann J; Chitadze G; Karawajew L; Brüggemann M; Eckert C
    J Mol Diagn; 2022 Aug; 24(8):856-866. PubMed ID: 35691569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of minimal residual disease in patients with t(15;17).
    Grimwade D
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):137-58. PubMed ID: 11987921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of Exosomal PML-RARA Fusion Gene Expression Level by Droplet Digital PCR].
    Zhu H; Wang ZY; Ding XQ; Wang RX; Pan XR; Tong JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):747-752. PubMed ID: 31204926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia.
    Ansuinelli M; Della Starza I; Lauretti A; Elia L; Siravo V; Messina M; De Novi LA; Taherinasab A; Canichella M; Guarini A; Foà R; Chiaretti S
    Hematol Oncol; 2021 Dec; 39(5):680-686. PubMed ID: 34402088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RT-PCR method with increased sensitivity shows persistence of PML-RARA fusion transcripts in patients in long-term remission of APL.
    Tobal K; Liu Yin JA
    Leukemia; 1998 Sep; 12(9):1349-54. PubMed ID: 9737682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.